Suppr超能文献

特发性血小板减少性紫癜中淋巴细胞的功能特性

Functional properties of lymphocytes in idiopathic thrombocytopenic purpura.

作者信息

Webber N P, Mascarenhas J O, Crow M K, Bussel J, Schattner E J

机构信息

Department of Pediatrics, Weill Medical College of Cornell University, New York, NY 10021, USA.

出版信息

Hum Immunol. 2001 Dec;62(12):1346-55. doi: 10.1016/s0198-8859(01)00348-2.

Abstract

Idiopathic or immune thrombocytopenic purpura (ITP) is characterized by antibody-mediated destruction of platelets. The etiology is unknown. We postulated that increased autoantibody production in ITP might be attributable to either increased or prolonged expression of CD40 ligand (CD40L, CD154) in T or B lymphocytes, as has been previously observed in systemic lupus erythematosus (SLE). In addition, we hypothesized that ITP is characterized by increased levels of interleukin 4 (IL-4), a prototypic Th2 cytokine which, along with CD40 ligation, is required for B cell differentiation and production of several IgG subclasses. Cell surface CD154 expression was measured in freshly-isolated and in vitro-activated peripheral blood lymphocytes of sixteen ITP patients and eight healthy volunteers. Plasma levels of IL-4 and the prototypic Th1 cytokine interferon-gamma (IFNgamma) were determined. We observed that CD154 expression in unstimulated and in vitro-activated lymphocytes did not differ between ITP patients and healthy controls. Plasma levels of the Th2 cytokine IL-4 were significantly higher in the ITP patients. These studies indicate that overexpression of CD154 in lymphocytes is unlikely to be a primary pathophysiological defect in most patients with ITP. The data support that in addition to cell membrane antigens such as CD154, soluble cytokines such as IL-4 should be considered as potential targets for therapy in this disease.

摘要

特发性或免疫性血小板减少性紫癜(ITP)的特征是抗体介导的血小板破坏。其病因尚不清楚。我们推测,ITP中自身抗体产生增加可能归因于T或B淋巴细胞中CD40配体(CD40L,CD154)表达增加或延长,正如先前在系统性红斑狼疮(SLE)中所观察到的那样。此外,我们假设ITP的特征是白细胞介素4(IL-4)水平升高,IL-4是一种典型的Th2细胞因子,与CD40连接一起,是B细胞分化和几种IgG亚类产生所必需的。在16例ITP患者和8名健康志愿者的新鲜分离和体外激活的外周血淋巴细胞中测量细胞表面CD154表达。测定血浆中IL-4和典型的Th1细胞因子干扰素-γ(IFNγ)水平。我们观察到,ITP患者和健康对照之间未刺激和体外激活的淋巴细胞中CD154表达没有差异。ITP患者中Th2细胞因子IL-4的血浆水平显著更高。这些研究表明,淋巴细胞中CD154的过表达不太可能是大多数ITP患者的主要病理生理缺陷。数据支持,除了CD154等细胞膜抗原外,IL-4等可溶性细胞因子应被视为该疾病治疗的潜在靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验